Translation of "Malignant hypertension" in German

Safety in malignant hypertension is not established.

Treatment of malignant hypertension is a competent selection of drugs.

But malignant hypertension requires a different approach.

How is malignant hypertension different from benign.

Substitution by nicotine is a risk factor for malignant hypertension in patients with hypertension.

In dialysis patients with malignant hypertension and hypovolaemia, a marked decrease in blood pressure can occur.

And he was reversing diabetes, he was reversing malignant hypertension, reversing heart disease, the diabetic complications, reversing diabetic blindness.

Without adequate therapy, a person with malignant hypertension faces death.

In some instances they can even turn "benign" hypertension into malignant hypertension.

In the absence of treatment, the prognosis for AME is severe with malignant hypertension, stroke, cardiac and renal insufficiency.

Arterial malignant hypertension means regular medical supervision, a certain discipline on the part of the patient.

But malignant hypertension develops dramatically, and correcting it is much harder to treat.

Because of the hypotensive activity, the new active substances are suitable for the treatment and prophylaxis of cardiovascular diseases, such as, for example, essential and malignant hypertension, cardiac insufficiency, angina pectoris and disturbances of the peripheral circulation.

Malignant hypertension - a disease that often affects men who have not yet reached 40 years.

Pharmacological effects are relatively diverse, but aimed at solving one important problem - the elimination of the manifestations of malignant arterial hypertension.

On the basis of their pharmacological properties, the compounds according to the invention can be employed for treatment and/or prophylaxis of cardiovascular diseases, in particular cardiac insufficiency, coronary heart disease, angina pectoris, myocardial infarction, stroke, arteriosclerosis, essential, pulmonary and malignant hypertension and peripheral arterial occlusive disease.

On the basis of its pharmacological properties, the compound of the formula (II) according to the invention can be employed for the treatment and/or prophylaxis of cardiovascular diseases, in particular cardiac insufficiency, coronary heart disease, angina pectoris, myocardial infarction, stroke, arteriosclerosis, essential, pulmonary and malignant hypertension and peripheral arterial occlusive disease.

Also for pre-eclampsia and certain forms of malignant blood hypertension, auto-antibodies have been described which contribute to the hyperactivation of cells by stimulating their angiotensin receptor or a 1 receptor, and participate in the genesis of defined clinical pictures.

Pathologically, damage to the blood vessels either by vasculitis or from malignant hypertension (for example) can result in fibrinoid necrosis .

In case of malignant arterial hypertension of the 2nd degree, the patient is assigned a disability of the 2nd group, in which work is contraindicated.

In case of a malignant course of hypertension, even with an improvement in the state, it is impossible to cancel or reduce the dosage of drugs prescribed by the doctor.

Corinfar not contraindicated, but requires careful use in mitral valve stenosis, obstruction of the gastrointestinal tract, hypertrophy of the wall of the left or right ventricular bradycardia or fibrillation, the rhythm disturbance caused by the weakening or termination function automatism sinoatrial node, kidney or liver failure, malignant hypertension, decrease in circulating blood volume, severe cerebral circulation disorders, myocardial infarction with left ventricular failure.

Other features of their course are high numbers of blood pressure, frequent complications, for which they were called "malignant" hypertension.

What could have caused the disease will become clear after a full examination, which a patient with malignant hypertension must undergo.

What does malignant hypertension mean?